# Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease

> **NCT01977781** · PHASE1 · COMPLETED · sponsor: **Massachusetts Eye and Ear Infirmary** · enrollment: 40 (actual)

## Conditions studied

- Ocular GVHD

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Methylprednisolone Sodium Succinate

## Key facts

- **NCT ID:** NCT01977781
- **Lead sponsor:** Massachusetts Eye and Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01977781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01977781, "Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01977781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*